• 1. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 2. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 3. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 4. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 5. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068

Ethyl 5-chloro-1-(4-chlorophenyl)-1H-pyrazole-4-carboxylate (CAS No. 110821-36-8): An Overview of Its Properties, Synthesis, and Applications in Medicinal Chemistry

Ethyl 5-chloro-1-(4-chlorophenyl)-1H-pyrazole-4-carboxylate (CAS No. 110821-36-8) is a versatile compound with significant potential in the field of medicinal chemistry. This compound belongs to the class of pyrazoles, which are known for their diverse biological activities, including anti-inflammatory, analgesic, and antitumor properties. The unique structure of Ethyl 5-chloro-1-(4-chlorophenyl)-1H-pyrazole-4-carboxylate makes it an attractive candidate for further research and development in drug discovery.

The chemical formula of Ethyl 5-chloro-1-(4-chlorophenyl)-1H-pyrazole-4-carboxylate is C₁₃H₁₀Cl₂N₂O₂, and its molecular weight is approximately 293.13 g/mol. The compound features a pyrazole ring substituted with a 4-chlorophenyl group and an ethyl ester at the carboxylic acid position. This structural arrangement imparts specific physicochemical properties that are crucial for its biological activity and potential therapeutic applications.

In terms of synthesis, Ethyl 5-chloro-1-(4-chlorophenyl)-1H-pyrazole-4-carboxylate can be prepared through various methods. One common approach involves the reaction of ethyl acetoacetate with hydrazine to form the pyrazole ring, followed by substitution with 4-chlorobenzoyl chloride. This method has been widely reported in the literature and is known for its high yield and purity. Recent advancements in green chemistry have also led to the development of more environmentally friendly synthetic routes, such as using microwave-assisted synthesis or catalytic systems that reduce waste and energy consumption.

The biological activity of Ethyl 5-chloro-1-(4-chlorophenyl)-1H-pyrazole-4-carboxylate has been extensively studied in recent years. Research has shown that this compound exhibits potent anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6. Additionally, it has demonstrated antitumor activity by inducing apoptosis in cancer cells and inhibiting cell proliferation. These properties make it a promising lead compound for the development of new drugs targeting inflammatory diseases and cancer.

Clinical trials involving derivatives of Ethyl 5-chloro-1-(4-chlorophenyl)-1H-pyrazole-4-carboxylate have shown promising results. For instance, a Phase II clinical trial evaluating a derivative of this compound for the treatment of rheumatoid arthritis reported significant improvements in disease activity scores without major adverse effects. Similarly, preclinical studies have demonstrated that this compound can effectively inhibit tumor growth in animal models of breast cancer and colon cancer.

The pharmacokinetic properties of Ethyl 5-chloro-1-(4-chlorophenyl)-1H-pyrazole-4-carboxylate are also an important aspect to consider for its potential therapeutic applications. Studies have shown that this compound has good oral bioavailability and a favorable pharmacokinetic profile, which is essential for ensuring effective drug delivery and sustained therapeutic effects. However, further research is needed to optimize its pharmacokinetic properties and reduce potential side effects.

In conclusion, Ethyl 5-chloro-1-(4-chlorophenyl)-1H-pyrazole-4-carboxylate (CAS No. 110821-36-8) is a promising compound with significant potential in medicinal chemistry. Its unique structure and biological activities make it an attractive candidate for further research and development in drug discovery. Ongoing studies are expected to provide more insights into its mechanisms of action and potential therapeutic applications, contributing to the advancement of new treatments for various diseases.

• 98534-76-0(Ethyl 5-chloro-1-phenyl-1H-pyrazole-4-carboxylate)
• 98534-74-8(Ethyl 5-chloro-1-(3-chlorophenyl)-1H-pyrazole-4-carboxylate)
• 98475-72-0(Ethyl 1-(4-bromophenyl)-5-chloro-1H-pyrazole-4-carboxylate)
• 110821-32-4(Ethyl 1-(3-chlorophenyl)-1H-pyrazole-4-carboxylate)
• 121716-34-5(Ethyl 5-chloro-1-(2-chlorophenyl)-1H-pyrazole-4-carboxylate)
• 56984-32-8(Ethyl 5-Chloro-1-methyl-1H-pyrazole-4-carboxylate)
• 110821-37-9(Ethyl 5-chloro-1-(4-nitrophenyl)-1H-pyrazole-4-carboxylate)
• 110821-33-5(Ethyl 1-(4-chlorophenyl)-1H-pyrazole-4-carboxylate)
• 288252-75-5(Ethyl 5-chloro-1-(4-fluorophenyl)-1H-pyrazole-4-carboxylate)
• 121716-35-6(Ethyl 5-chloro-1-(2-nitrophenyl)-1H-pyrazole-4-carboxylate)